The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
x This classification has been retracted/unpublished!
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_003159.2(CDKL5):c.146-1G>A

CA171613

158179 (ClinVar)

Gene: CDKL5
Condition: CDKL5 disorder
Inheritance Mode: X-linked inheritance (dominant (HP:0001423))
UUID: 0305323e-a1e9-44ca-a970-405bbb93be98

HGVS expressions

NM_003159.2:c.146-1G>A
NM_003159.2(CDKL5):c.146-1G>A
NC_000023.11:g.18575353G>A
CM000685.2:g.18575353G>A
NC_000023.10:g.18593473G>A
CM000685.1:g.18593473G>A
NC_000023.9:g.18503394G>A
NG_008475.1:g.154749G>A
ENST00000623535.2:c.146-1G>A
ENST00000635828.1:c.146-1G>A
ENST00000637881.1:c.146-1G>A
ENST00000674046.1:c.146-1G>A
ENST00000379989.6:c.146-1G>A
ENST00000379996.7:c.146-1G>A
ENST00000463994.4:c.146-1G>A
ENST00000623364.3:c.146-1G>A
ENST00000623535.1:c.146-1G>A
ENST00000624700.3:c.146-1G>A
NM_001037343.1:c.146-1G>A
NM_001323289.1:c.146-1G>A
NM_001323289.2:c.146-1G>A
NM_001037343.2:c.146-1G>A
NM_003159.3:c.146-1G>A
NM_001323289.2(CDKL5):c.146-1G>A

Likely Pathogenic

Met criteria codes 2
PVS1 PM2_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Rett and Angelman-like Disorders VCEP
The c.146-1G>A variant in CDKL5 is predicted to affect a canonical splice site and lead to a truncated or absent protein in a CDKL5 where loss-of-function is an established mechanism. There is significant evidence that loss of this region of the CDKL5 is pathogenic (PVS1). The c.146-1G>A variant in CDKL5 is absent from gnomAD (PM2_Supporting). In summary, the c.146-1G>A variant in CDKL5 is classified as likely pathogenic based on the ACMG/AMP criteria (PVS1, PM2_supporting).
Met criteria codes
PVS1
The c.146-1G>A variant in CDKL5 is predicted to affect a canonical splice site and lead to a truncated or absent protein in a CDKL5 where loss-of-function is an established mechanism. There is significant evidence that loss of this region of the CDKL5 is pathogenic
PM2_Supporting
The c.146-1G>A variant in CDKL5 is absent from gnomAD.
Approved on: 2021-04-02
Published on: 2024-02-29
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.